Dietary Impact in Association to Risk of Cancer and their Anticancer Immune Response
Dietary Impact on Cancer and Immune Response
The imbalance between modulation of the cell proliferation and apoptosis results in abnormal cell production which ultimately leads to the cancerous condition. During the 21st century, cancer is probably exceeded to infectious and other chronic diseases as the major cause of death in all countries. The increasing global prevalence ratio and a speedily rising population of cancer survivors focus on the ferocity of public health and economic challenges pretended this disease. This review summarizes the significant outcomes of dietary intake which can enhance the immune response and reduce the risk of cancer. The nutritional general mechanism of action to influence the immune function and the potential activity of anticancer immunotherapy are also studied. For several cancers immunotherapy has developed into standard treatment but considerably remains to be done to prolong the activity of its potential efficiency mainly to cancers that are unaffected within each indication. Although a higher consumption of plant foods like vegetables, fruits, legumes, nuts and whole grains has been suggested for cancer prevention, it has been undecided what is the prime amount of ingestion of these foods and whether particular subtypes are valuable. Several million premature mortalities can be prevented if a high intake of plant foods is adopted globally. Furthermore, for reducing the risk of different types of cancers and slow down their development many dietary products have been proven advantageous.
Keywords: Cancer, Immune system, Dietary items, Immunotherapy, Nutritional balance.
2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018; 68(6):394-424.
3. Habib A, Jaffar G, Khalid MS, et al. Risk Factors Associated with Prostate Cancer. Journal of Drug Delivery and Therapeutics. 2021; 11(2):188-193.
4. Marmot M, Atinmo T, Byers T, et al. World Cancer Research Fund/American Institute of CAncer REsearch, Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. 2007.
5. Lallukka T, Millear A, Pain A, Cortinovis M, Giussani G. GBD 2015 mortality and causes of death collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specifi c mortality for 249 causes of death, 1980-2015: a systematic analysis for the global burden of disease study 2015. Lancet Oncoloy. 2017; 389(10064):E1-E1.
6. Foerster SB, Kizer KW, DiSogra LK, Bal DG, Krieg BF, Bunch KL. California’s “5 a day—for better health!” campaign: An innovative population-based effort to effect large-scale dietary change. American Journal of Preventive Medicine. 1995; 11(2):124-131.
7. Bere E, Hilsen M, Klepp K-I. Effect of the nationwide free school fruit scheme in Norway. British Journal of Nutrition. 2010; 104(4):589-594.
8. Habib A, Anjum KM, Shehzad A, Imran M, Ashraf Z, Ramzan M. Outbreak of COVID-19 pandemic in Pakistan and the current scenario. The Applied Biology and Chemistry Journal. 2020; 1(2):67-71.
9. Habib A, Principe UE, Ashraf Z, Imran M. Epidemiology of Rabies and the Control Challenges. Biotica Research Today. 2020; 2(11):1201-1204.
10. Michels KB, Giovannucci E, Joshipura KJ, et al. Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. Journal of the National Cancer Institute. 2000; 92(21):1740-1752.
11. Terry P, Giovannucci E, Michels KB, et al. Fruit, vegetables, dietary fiber, and risk of colorectal cancer. Journal of the National Cancer Institute. 2001; 93(7):525-533.
12. Van Gils CH, Peeters PH, Bueno-de-Mesquita HB, et al. Consumption of vegetables and fruits and risk of breast cancer. Jama. 2005; 293(2):183-193.
13. Emens LA, Ascierto PA, Darcy PK, et al. Cancer immunotherapy: opportunities and challenges in the rapidly evolving clinical landscape. European Journal of Cancer. 2017; 81:116-129.
14. Masucci GV, Cesano A, Eggermont A, et al. The need for a network to establish and validate predictive biomarkers in cancer immunotherapy. Journal of Translational Medicine. 2017;15(1):1-10.
15. Wang E, Uccellini L, Marincola FM. A genetic inference on cancer immune responsiveness. Oncoimmunology. 2012; 1(4):520-525.
16. Davis MM, Tato CM, Furman D. Systems immunology: just getting started. Nature Immunology. 2017; 18(7):725.
17. Renner K, Singer K, Koehl GE, et al. Metabolic hallmarks of tumor and immune cells in the tumor microenvironment. Frontiers in Immunology. 2017; 8:248.
18. De Rosa V, Di Rella F, Di Giacomo A, Matarese G. Regulatory T cells as suppressors of anti-tumor immunity: role of metabolism. Cytokine & Growth Factor Reviews. 2017; 35:15-25.
19. Morabito G, Kucan P, Serafini M. Prevention of postprandial metabolic stress in humans: role of fruit-derived products. Endocrine, Metabolic & Immune Disorders-Drug Targets. 2015; 15(1):46-53.
20. Peluso I, V Villano D, A Roberts S, et al. Consumption of mixed fruit-juice drink and vitamin C reduces postprandial stress induced by a high fat meal in healthy overweight subjects. Current Pharmaceutical Design. 2014; 20(6):1020-1024.
21. Casas R, Sacanella E, Estruch R. The immune protective effect of the Mediterranean diet against chronic low-grade inflammatory diseases. Endocrine, Metabolic & Immune Disorders-Drug Targets. 2014; 14(4):245-254.
22. Campisi J. Aging, cellular senescence, and cancer. Annual Review of Physiology. 2013; 75:685-705.
23. Haase H, Rink L. The immune system and the impact of zinc during aging. Immunity & Ageing. 2009; 6(1):1-17.
24. Prasad AS. Discovery of human zinc deficiency: its impact on human health and disease. Advances in Nutrition. 2013; 4(2):176-190.
25. Mocchegiani E, Costarelli L, Giacconi R, Piacenza F, Basso A, Malavolta M. Zinc, metallothioneins and immunosenescence: effect of zinc supply as nutrigenomic approach. Biogerontology. 2011; 12(5):455-465.
26. Magrone T, Pugliese V, Fontana S, Jirillo E. Human use of Leucoselect® Phytosome® with special reference to inflammatory-allergic pathologies in frail elderly patients. Current Pharmaceutical Design. 2014; 20(6):1011-1019.
27. Amati L, Marzulli G, Martulli M, et al. Administration of a synbiotic to free-living elderly and evaluation of serum cytokines. A pilot study. Current Pharmaceutical Design. 2010; 16(7):854-858.
28. Marelli G, Sica A, Vannucci L, Allavena P. Inflammation as target in cancer therapy. Current Opinion in Pharmacology. 2017; 35:57-65.
29. Coussens LM, Zitvogel L, Palucka AK. Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science. 2013; 339(6117):286-291.
30. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008; 454(7203):436-444.
31. Tudek B, Zdżalik-Bielecka D, Tudek A, Kosicki K, Fabisiewicz A, Speina E. Lipid peroxidation in face of DNA damage, DNA repair and other cellular processes. Free Radical Biology and Medicine. 2017; 107:77-89.
32. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell. 2006; 124(2):263-266.
33. Mantovani A, Romero P, Palucka AK, Marincola FM. Tumour immunity: effector response to tumour and role of the microenvironment. The Lancet. 2008; 371(9614):771-783.
34. Iida N, Dzutsev A, Stewart CA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013; 342(6161):967-970.
35. Baena R, Salinas P. Diet and colorectal cancer. Maturitas. 2015; 80(3):258-264.
36. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutrition and Cancer. 1992; 18(1):1-29.
37. Bingham S. Diet and colorectal cancer prevention. Biochemical Society Transactions. 2000; 28(2):12-16.
38. Unisa S, Jagannath P, Dhir V, Khandelwal C, Sarangi L, Roy TK. Population-based study to estimate prevalence and determine risk factors of gallbladder diseases in the rural Gangetic basin of North India. Hepato-Pancreato-Biliary Association. 2011; 13(2):117-125.
39. Yuan W, Yang N, Li X. Advances in understanding how heavy metal pollution triggers gastric cancer. BioMed Research International. 2016; 2016.
40. Chhabra D, Oda K, Jagannath P, Utsunomiya H, Takekoshi S, Nimura Y. Chronic heavy metal exposure and gallbladder cancer risk in India, a comparative study with Japan. Asian Pacific Journal of Cancer Prevention. 2012; 13(1):187-190.
41. Lin S-H, Li Y-H, Leung K, Huang C-Y, Wang X-R. Salt processed food and gastric cancer in a Chinese population. Asian Pacific Journal of Cancer Prevention. 2014; 15(13):5293-5298.
42. Cascella M, Bimonte S, Barbieri A, et al. Dissecting the mechanisms and molecules underlying the potential carcinogenicity of red and processed meat in colorectal cancer (CRC): an overview on the current state of knowledge. Infectious Agents and Cancer. 2018; 13(1):1-8.
43. Kobylewski S, Jacobson MF. Toxicology of food dyes. International Journal of Occupational and Environmental Health. 2012; 18(3):220-246.
44. Pietrzyk Ł. Food properties and dietary habits in colorectal cancer prevention and development. International Journal of Food Properties. 2017; 20(10):2323-2343.
45. Laher J, Rigler M, Vetter R, Barrowman J, Patton J. Similar bioavailability and lymphatic transport of benzo (a) pyrene when administered to rats in different amounts of dietary fat. Journal of Lipid Research. 1984; 25(12):1337-1342.
46. Abnet CC. Carcinogenic food contaminants. Cancer investigation. 2007;25(3):189-196.
47. Habib A, Jaffar G, Khalid M. Letter to Editor: Challenges in the Development of Hepatitis C Vaccine. International Journal of Biomedical Investigation. 2020; 3: 127.
48. Hamid AS, Tesfamariam IG, Zhang Y, Zhang ZG. Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and prevention. Oncology Letters. 2013; 5(4):1087-1092.
49. Simanowski U, Homann N, Knühl M, et al. Increased rectal cell proliferation following alcohol abuse. Gut. 2001; 49(3):418-422.
50. Pfeffer CM, Singh AT. Apoptosis: a target for anticancer therapy. International Journal of Molecular Sciences. 2018; 19(2):448.
51. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-674.
52. D’Eliseo D, Velotti F. Omega-3 fatty acids and cancer cell cytotoxicity: implications for multi-targeted cancer therapy. Journal of Clinical Medicine. 2016; 5(2):15.
53. Moloudizargari M, Mortaz E, Asghari MH, Adcock IM, Redegeld FA, Garssen J. Effects of the polyunsaturated fatty acids, EPA and DHA, on hematological malignancies: a systematic review. Oncotarget. 2018; 9(14):11858.
54. Zimmer AR, Leonardi B, Miron D, Schapoval E, de Oliveira JR, Gosmann G. Antioxidant and anti-inflammatory properties of Capsicum baccatum: from traditional use to scientific approach. Journal of Ethnopharmacology. 2012; 139(1):228-233.
55. Lin R-J, Wu I-J, Hong J-Y, et al. Capsaicin-induced TRIB3 upregulation promotes apoptosis in cancer cells. Cancer Management and Research. 2018; 10:4237.
56. Amantini C, Mosca M, Nabissi M, et al. Capsaicin‐induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation. Journal of Neurochemistry. 2007; 102(3):977-990.
57. Ying H, Wang Z, Zhang Y, et al. Capsaicin induces apoptosis in human osteosarcoma cells through AMPK-dependent and AMPK-independent signaling pathways. Molecular and Cellular Biochemistry. 2013; 384(1):229-237.
58. Lee S-H, Richardson RL, Dashwood RH, Baek SJ. Capsaicin represses transcriptional activity of β-catenin in human colorectal cancer cells. The Journal of Nutritional Biochemistry. 2012; 23(6):646-655.
59. Lee Y-H, Chen H-Y, Su LJ, Chueh PJ. Sirtuin 1 (SIRT1) deacetylase activity and NAD+/NADH ratio are imperative for capsaicin-mediated programmed cell death. Journal of Agricultural and Food Chemistry. 2015; 63(33):7361-7370.
60. Amantini C, Ballarini P, Caprodossi S, et al. Triggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of urothelial cancer cells in an ATM-dependent manner. Carcinogenesis. 2009; 30(8):1320-1329.
61. Chow J, Norng M, Zhang J, Chai J. TRPV6 mediates capsaicin-induced apoptosis in gastric cancer cells—Mechanisms behind a possible new “hot” cancer treatment. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2007; 1773(4):565-576.
62. Ito K, Nakazato T, Yamato K, et al. Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer Research. 2004; 64(3):1071-1078.
63. Lee Y-R, Chen M, Lee JD, et al. Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway. Science. 2019; 364(6441).
64. Borzì AM, Biondi A, Basile F, Luca S, Vicari ESD, Vacante M. Olive oil effects on colorectal cancer. Nutrients. 2019; 11(1):32.
65. Kamm W, Dionisi F, Hischenhuber C, Engel K-H. Authenticity assessment of fats and oils. Food Reviews International. 2001; 17(3):249-290.
66. Kalogeropoulos N, Tsimidou MZ. Antioxidants in Greek virgin olive oils. Antioxidants. 2014; 3(2):387-413.
67. Owen R, Haubner R, Würtele G, Hull W, Spiegelhalder B, Bartsch H. Olives and olive oil in cancer prevention. European Journal of Cancer Prevention. 2004; 13(4):319-326.
68. Zong J, Martirosyan DM. Anticancer effects of garlic and garlic-derived bioactive compounds and its potential status as functional food. Bioactive Compounds in Health and Disease. 2018; 1(2):16-35.
69. Song K, Milner JA. The influence of heating on the anticancer properties of garlic. The Journal of Nutrition. 2001; 131(3):1054S-1057S.
70. Myneni AA, Chang S-C, Niu R, et al. Raw garlic consumption and lung cancer in a Chinese population. Cancer Epidemiology and Prevention Biomarkers. 2016; 25(4):624-633.
71. Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene. 2001; 20(23):2927-2936.
72. Howells LM, Gallacher-Horley B, Houghton CE, Manson MM, Hudson EA. Indole-3-carbinol Inhibits Protein Kinase B/Akt and Induces Apoptosis in the Human Breast Tumor Cell Line MDA MB468 but not in the Nontumorigenic HBL100 Line 1 Supported by the United Kingdom Medical Research Council. These data have been published in a preliminary form as an abstract. Molecular Cancer Therapeutics. 2002; 1(13):1161-1172.
73. Hong C, Kim H-A, Firestone GL, Bjeldanes LF. 3, 3′-Diindolylmethane (DIM) induces a G1 cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21WAF1/CIP1 expression. Carcinogenesis. 2002; 23(8):1297-1305.
74. Amantini C, Ballarini P, Caprodossi S, et al. Triggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of urothelial cancer cells in an ATM-dependent manner. Carcinogenesis. 2009; 30(8):1320-1329.
75. Lau JK, Brown KC, Dom AM, et al. Capsaicin induces apoptosis in human small cell lung cancer via the TRPV6 receptor and the calpain pathway. Apoptosis. 2014; 19(8):1190-1201.
76. Amantini C, Mosca M, Nabissi M, et al. Capsaicin‐induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation. Journal of Neurochemistry. 2007; 102(3):977-990.
77. Lin C-H, Lu W-C, Wang C-W, Chan Y-C, Chen M-K. Capsaicin induces cell cycle arrest and apoptosis in human KB cancer cells. BMC Complementary and Alternative Medicine. 2013; 13(1):1-9.
78. Chimento A, Casaburi I, Rosano C, et al. Oleuropein and hydroxytyrosol activate GPER/GPR 30‐dependent pathways leading to apoptosis of ER‐negative SKBR 3 breast cancer cells. Molecular Nutrition & Food Research. 2014; 58(3):478-489.
79. LeGendre O, Breslin PA, Foster DA. (-)-Oleocanthal rapidly and selectively induces cancer cell death via lysosomal membrane permeabilization. Molecular & Cellular Oncology. 2015; 2(4):1006077.
80. Elamin MH, Daghestani MH, Omer SA, et al. Olive oil oleuropein has anti-breast cancer properties with higher efficiency on ER-negative cells. Food and Chemical Toxicology. 2013; 53:310-316.
81. Khanfar MA, Bardaweel SK, Akl MR, El Sayed KA. Olive oil‐derived oleocanthal as potent inhibitor of mammalian target of rapamycin: biological evaluation and molecular modeling studies. Phytotherapy Research. 2015; 29(11):1776-1782.
82. Teodoro AJ, Oliveira FL, Martins NB, de Azevedo Maia G, Martucci RB, Borojevic R. Effect of lycopene on cell viability and cell cycle progression in human cancer cell lines. Cancer Cell International. 2012; 12(1):1-9.
83. Tang L, Jin T, Zeng X, Wang J-S. Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice. The Journal of Nutrition. 2005; 135(2):287-290.
84. Zhang B, Gu Y. Low expression of ERK signaling pathway affecting proliferation, cell cycle arrest and apoptosis of human gastric HGC-27 cells line. Molecular Biology Reports. 2014; 41(6):3659-3669.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).